scanX
Shilpa Medicare
add_icon

Shilpa Medicare

861.55
+5.75
(0.67%)
Market Cap
16,850.35 Cr
PE Ratio
56.34
Volume
12,01,334.00
Day High - Low
869.00 - 835.50
52W High-Low
866.65 - 259.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
16,850.35 Cr
EPS
12.44
PE Ratio
56.34
PB Ratio
6.46
Book Value
132.49
EBITDA
444.50
Dividend Yield
0.07 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
9.39
Debt to Equity
0.25
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
negative
Shilpa Medicare recalls 27,923 vials of chemo drug in US7 days ago
Shilpa Medicare has initiated a voluntary recall of 27,923 vials of a chemotherapy drug in the United States. The recall underscores regulatory compliance activity in the US market.
positive
Shilpa Medicare declares 60% dividend for FY26Aug 14, 2026
Shilpa Medicare recommends a final dividend of Re. 0.60 per share for FY26, subject to shareholder approval at the upcoming AGM on September 11, 2026.
neutral
Shilpa Medicare Q1FY27 Call RecordingAug 05, 2026
Shilpa Medicare Limited has uploaded the audio recording of its Q1FY27 earnings conference call held on August 5, 2026, for investor access.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,922.00
#1 4,61,152.18
37.82
#1 61,673.90
12.69
#1 11,565
26.53
49.61
Divis Laboratories
8,744.50
2,32,139.00
77.15
11,067.00
13.95
2,568
65.50
73.16
Torrent Pharmaceuticals
4,932.00
1,87,597.43
85.76
13,886.20
20.34
2,138
3.28
51.36
Cipla
1,422.00
1,14,875.60
34.55
29,044.60
2.24
3,870
-39.18
42.83
Zydus Life Science
1,124.50
1,13,151.01
23.91
27,657.90
17.64
5,026
-34.90
49.80
Laurus Labs
1,866.20
1,00,748.04
89.01
6,867.80
22.01
890
#1 123.93
68.10
Dr Reddys Laboratories
1,193.50
99,617.75
31.32
35,058.60
3.90
4,158
-69.10
49.57
Lupin
2,175.50
99,470.94
#1 18.04
29,038.90
#1 26.75
5,356
16.00
26.80
Mankind Pharma
2,365.00
97,673.55
47.44
14,636.40
14.85
1,938
29.13
37.36
Aurobindo Pharma
1,617.80
93,084.64
24.96
34,145.20
5.56
3,503
25.21
53.16
Growth Rate
Revenue Growth
18.24 %
Net Income Growth
210.73 %
Cash Flow Change
158.70 %
ROE
183.69 %
ROCE
65.20 %
EBITDA Margin (Avg.)
9.67 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
168
151
177
202
203
168
219
186
231
174
209
191
241
203
192
177
203
163
296
241
229
289
288
200
215
239
306
278
346
269
267
266
266
262
315
289
300
302
349
321
341
328
372
411
482
475
Expenses
129
120
137
158
146
139
161
151
171
133
155
159
189
149
128
153
163
132
223
163
175
158
210
171
182
206
243
228
268
241
253
231
227
214
255
222
222
223
258
239
282
231
262
309
317
330
EBITDA
39
31
40
44
58
30
58
35
60
40
54
31
53
54
64
24
41
31
73
78
54
131
78
29
33
33
62
50
78
28
14
34
39
48
60
67
79
80
91
82
59
97
110
102
165
145
Operating Profit %
23 %
19 %
21 %
21 %
26 %
16 %
23 %
17 %
23 %
20 %
24 %
14 %
20 %
25 %
21 %
12 %
19 %
18 %
23 %
31 %
21 %
29 %
25 %
11 %
12 %
13 %
18 %
16 %
21 %
8 %
4 %
12 %
14 %
18 %
19 %
23 %
24 %
24 %
25 %
25 %
15 %
28 %
29 %
25 %
27 %
29 %
Depreciation
5
5
6
6
6
7
7
8
8
9
8
9
11
10
10
11
11
11
11
11
12
12
13
14
15
18
19
21
22
22
23
24
26
27
28
27
27
27
28
29
29
29
30
30
31
35
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
4
4
5
9
10
12
10
9
10
14
18
18
18
23
26
24
24
26
12
15
19
16
11
14
12
Profit Before Tax
32
25
34
37
50
22
50
27
51
31
46
22
41
43
53
11
29
19
62
65
42
115
61
11
8
5
32
19
46
-4
-22
-8
-4
3
9
14
28
29
37
42
15
50
64
61
120
98
Tax
10
7
12
10
12
8
12
10
14
9
12
5
10
10
11
-1
6
4
11
11
8
29
16
3
1
4
12
10
17
-6
-4
-1
4
2
8
10
3
15
19
10
1
3
20
16
13
-3
Net Profit
22
18
22
27
38
14
38
17
37
22
34
16
31
33
42
12
23
15
51
55
34
86
45
8
8
2
20
10
30
2
-19
-7
-8
1
2
5
25
14
18
32
15
47
44
45
108
101
EPS in ₹
5.86
4.70
6.05
3.60
4.27
1.92
4.97
2.03
4.33
2.77
4.21
2.29
3.79
4.28
5.22
1.46
2.93
1.93
6.23
6.75
4.24
10.59
5.57
0.94
0.96
0.19
2.45
1.13
3.40
0.10
-2.15
-0.76
-0.93
0.14
0.19
0.53
2.82
1.46
1.83
3.25
0.74
4.79
5.50
2.28
5.51
5.16
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
905
931
1,472
1,499
1,610
1,989
2,632
2,876
2,904
3,093
3,311
3,706
Fixed Assets
316
393
492
534
558
650
1,111
1,342
1,368
1,385
1,418
1,593
Current Assets
328
354
730
672
545
624
903
887
770
877
985
1,110
Capital Work in Progress
222
92
141
210
429
666
541
506
655
719
822
884
Investments
65
94
253
140
2
11
21
34
43
40
35
58
Other Assets
302
352
587
615
621
662
959
993
838
950
1,037
1,171
Total Equity & Liabilities
905
931
1,472
1,499
1,610
1,989
2,632
2,876
2,904
3,093
3,311
3,706
Current Liabilities
189
222
237
266
253
411
604
612
784
693
674
848
Non Current Liabilities
154
67
251
154
167
257
561
453
345
600
273
266
Total Equity
561
642
984
1,080
1,190
1,322
1,468
1,811
1,774
1,800
2,364
2,591
Reserve & Surplus
539
632
979
1,077
1,189
1,321
1,471
1,814
1,775
1,800
2,353
2,572
Share Capital
8
8
8
8
8
8
8
9
9
9
10
20
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
9
3
93
-26
-40
10
79
-98
-7
13
-3
17
Investing Activities
-196
-106
-257
-10
-196
-290
-404
-286
-232
-171
-198
-339
Operating Activities
69
129
38
45
147
124
47
105
180
137
132
342
Financing Activities
136
-20
313
-61
10
176
436
83
46
47
63
14
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
53.25 %
53.25 %
53.25 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
50.01 %
44.39 %
44.39 %
44.33 %
44.23 %
44.23 %
44.23 %
44.23 %
40.13 %
40.13 %
40.13 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.60 %
8.52 %
0.00 %
0.00 %
9.08 %
9.58 %
9.90 %
10.97 %
11.20 %
10.92 %
10.97 %
11.08 %
11.38 %
DIIs
2.95 %
2.05 %
2.29 %
2.15 %
2.12 %
1.01 %
1.01 %
1.01 %
0.61 %
0.54 %
0.00 %
0.41 %
0.06 %
1.59 %
6.13 %
7.61 %
8.18 %
8.27 %
7.55 %
7.46 %
7.67 %
8.33 %
8.58 %
8.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.80 %
17.89 %
19.49 %
18.23 %
18.57 %
20.12 %
20.51 %
18.95 %
21.85 %
24.05 %
26.82 %
25.40 %
25.45 %
27.64 %
24.54 %
24.69 %
23.94 %
24.40 %
24.43 %
23.21 %
23.34 %
27.80 %
27.70 %
27.67 %
Others
27.01 %
26.81 %
24.97 %
29.61 %
29.31 %
28.87 %
28.47 %
30.03 %
27.52 %
25.40 %
23.17 %
15.59 %
15.96 %
20.75 %
24.94 %
14.23 %
13.96 %
13.21 %
12.83 %
13.90 %
13.84 %
12.76 %
12.51 %
12.76 %
No of Share Holders
51,277
53,220
46,540
40,592
39,565
39,724
39,097
41,579
46,143
46,869
50,434
44,094
43,630
44,793
44,809
41,072
42,784
49,034
50,108
48,636
52,065
53,799
53,410
60,926

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.6 0.7 1 1.1 1.1 1.1 0.00 0.00 1 0.6
Dividend Yield (%) 0.26 0.41 0.82 0.66 0.55 0.96 0.00 0.00 0.29 0.07

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 11 Sept 2026 644.65 855.80
04 Sept 2026 DIVIDEND Dividend
₹ 0.60 /share
 04 Sept 2026 475.15 855.80
22 Sept 2021 DIVIDEND Dividend
₹ 1.10 /share
 20 Sept 2021 257.93 277.10
20 Sept 2022 DIVIDEND Dividend
₹ 1.10 /share
 19 Sept 2022 210.73 187.95
17 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 17 Sept 2024 353.38 447.35
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Nov 2024 421.15 437.78
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 10 Feb 2025 347.75 365.43
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 26 May 2025 353.98 390.75
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Aug 2025 425.20 435.10
17 Sept 2025 DIVIDEND Dividend
₹ 1.00 /share
 17 Sept 2025 390.75 413.13
23 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 23 Sept 2025 435.10 408.63
03 Oct 2025 BONUS Bonus
1:1
 03 Oct 2025 410.65 389.38
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 Nov 2025 357.50 399.65
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Feb 2026 269.95 315.90
22 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 May 2026 438.55 475.15
05 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Aug 2026 605.30 644.65

Announcements

Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent /Depository Participants6 days ago
Response On The News Item Captioned Shilpa Medicare Recalls Over 27K Vials Of Chemotherapy Drug In US Published In The Online Edition Of The Economic Times On August 17 2026 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure 7 days ago
Announcement under Regulation 30 (LODR)-Dividend Updates8 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2026
Reg. 34 (1) Annual Report.Aug 13, 2026
39Th Annual General Meeting NoticeAug 13, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 05, 2026
Final Dividend For The FY 2025-26Aug 05, 2026
Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026Aug 05, 2026
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended 30 June 2026Aug 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2026
Board Meeting Intimation for Quarterly Financial ResultsJul 29, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJul 16, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 15, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJul 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 26, 2026
Closure of Trading WindowJun 25, 2026
M/S Shilpa Biologicals Pvt. Ltd A Material Subsidiary Of Shilpa Medicare Limited And M/S Sartorius Stedim India Pvt. Ltd. Have Entered Into A Settlement AgreementJun 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 24, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 24, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 23, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 03, 2026
USFDA Inspection Of Shilpa Medicare Ltd At Unit VI Dabaspet BengaluruMay 30, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 22, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 22, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 22, 2026
Board Meeting Outcome for Outcome Of The Board MeetingMay 22, 2026
Financial ResultsMay 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2026
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 14, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 22, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Closure of Trading WindowMar 25, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 17, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 05, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2026
Revised Attachment To Annexure - I. On Execution Of Agreement With NXI Therapeutics AGFeb 14, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Healthcare Fund Direct-Growth
2.49%
-20000
-0.29%
0.08%
Samco Small Cap Fund Direct-Growth
0.66%
11864
0.41%
0.66%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.03%
-6
0.00%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Samco Special Opportunities Fund Direct-Growth
2.12%
0
0.00%
2.12%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.45%
0
0.00%
0.00%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.58%
0
0.00%
0.00%
Bandhan Innovation Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.43%
0
0.00%
-0.04%
Groww Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
HDFC Pharma And Healthcare Fund Direct-Growth
2.25%
0
0.00%
-0.23%
ICICI Prudential ELSS Tax Saver Direct Plan-Growth
0.88%
0
0.00%
0.00%
ICICI Prudential Exports and Services Fund Direct-Growth
0.97%
0
0.00%
0.01%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth
0.00%
0
0.00%
0.00%
ITI Pharma and Healthcare Fund Direct-Growth
1.15%
0
0.00%
-0.03%
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
1.49%
0
0.00%
-0.04%
Angel One Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Samco Active Momentum Fund Direct-Growth
1.93%
0
0.00%
1.93%
Aditya Birla Sun Life Retirement Fund - The 30s Plan Direct-Growth
1.20%
0
0.00%
-1.20%
Samco Multi Cap Fund Direct-Growth
0.41%
0
0.00%
0.41%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
2.32%
0
0.00%
-0.09%
Motilal Oswal Nifty Microcap 250 Index Fund Direct-Growth
0.79%
0
0.00%
0.01%
Union Active Momentum Fund Direct-Growth
1.80%
0
0.00%
1.80%
WhiteOak Capital Balanced Advantage Fund Direct-Growth
0.16%
0
0.00%
-0.01%

Technical Indicators

RSI(14)
Neutral
79.20
ATR(14)
Volatile
30.14
STOCH(9,6)
Overbought
82.58
STOCH RSI(14)
Neutral
60.84
MACD(12,26)
Bullish
3.73
ADX(14)
Very Strong Trend
53.73
UO(9)
Bearish
56.20
ROC(12)
Uptrend And Accelerating
15.84
WillR(14)
Overbought
-4.72
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104